Robert Weinstein - Nov 20, 2023 Form 4 Insider Report for PharmaCyte Biotech, Inc. (PMCB)

Role
Director
Signature
/s/ Robert Weinstein
Stock symbol
PMCB
Transactions as of
Nov 20, 2023
Transactions value $
$0
Form type
4
Date filed
11/22/2023, 05:02 PM
Previous filing
May 31, 2023
Next filing
Jul 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMCB Stock Option (Right to Buy) Award $0 +61.2K $0.00 61.2K Nov 20, 2023 Common Stock 61.2K $2.18 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.